Sankesh Abbhi - 10 Dec 2021 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
Director
Signature
/s/ Sankesh Abbhi
Issuer symbol
BCLI
Transactions as of
10 Dec 2021
Net transactions value
$0
Form type
4
Filing time
10 Dec 2021, 19:02:02 UTC

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +6,666 +143% $0.000000 11,323 10 Dec 2021 Direct F1
holding BCLI Common Stock 2,164,530 10 Dec 2021 Abbhi Investments, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired are shares of restricted stock awarded pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vested in 12 consecutive, equal monthly installments commencing on the one month anniversary of April 6, 2021 until fully vested on the 12 month anniversary of April 6, 2021, provided that the Reporting Person remained a member of the Board of Directors of the Issuer on each vesting date.
F2 Abbhi Investments, LLC is the record owner of these securities. Mr. Sankesh Abbhi is the manager of Abbhi Investments, LLC and maintains sole voting and investment power with respect to common stock and warrants held by Abbhi Investments, LLC.